Become a member

Author: amathias@igtcreative.fr

AMKbiotech – new member

AMKbiotech

AMKbiotech is a CRO providing the biomedical actors with a specialized expertise and tailored services in high-plex spatial biology and cytometry for biomarker identification and treatment efficacy validation.

Valerio Therapeutics – new member

VALERIO THERAPEUTICS

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions.

ETAP-Lab annonce l’acquisition de SYNCROSOM

10 Octobre 2023 – ETAP-Lab, société de recherche sur contrat (CRO) préclinique spécialisée en Neurologie et Dermatologie, annonce l’acquisition de SYNCROSOME (PACA), CRO préclinique spécialisée dans les pathologies cardio-pulmonaires. Cette acquisition marque une étape significative dans l’évolution d’ETAP-Lab et renforce sa position en tant que CRO préclinique de premier plan. En savoir plus

Innate Pharma – new member

Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Catalent France – new member

Catalent France Limoges SAS

Catalent Limoges is dedicated to the development and manufacture of new biological drugs in the clinical phase, using new-generation molecules.

Arthritis4Cure – new member

Arthritis4Cure is developing research and development activities, with a particular focus on biomedicines, cell therapies and other therapies for autoimmune diseases.

AR2i – new member

AR2i

AR2i is a Contract Research Organisation (CRO)-type research and development laboratory.

PD-value – New International Member

PD-value provides pharmaceutical clients with customized, state-of-the-art modeling and simulation services in systems biology, translational pharmacology&pharmacometrics (PK-PD, PBPK, QSP), and consultancy to support decision-making in every stage of drug development.

Alvéole – new member

Alvéole is a company specialized in devices for controlling the cellular microenvironment.

OSIVAX – new member

Osivax is developing a new class of universal vaccines empowering both arms of the immune system.

Bio-Techne – new member

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services.

Linksium – new member

Linksium is a pioneering large-scale creation of technological startups emanating from public research.

Affilogic – new member

Affilogic is a private biotech company specialized in discovering and developing Nanofitins® .

AGPOC – nouveau membre

AGPOC apporte des conseils aux CDMO Biotech et Pharma pour la partie commerciale et l’alliance management.

Kimialys – new member

Kimialys provides services and ready-to-use biochips and nanoparticles, coated with off-the-shelf or customized surface chemistries, to SPR users and LFA developers looking for innovative immobilisation methods.

Adjuvatis – new member

Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for immunotherapies, oncology, bacterial infections, etc.

Tebubio – new member

Tebubio is a pan-european company helping to advance Life Sciences research every day.

Biophact – new member

Biophact is dedicated to support, help and assist the birth and growth of Biotech/Pharma companies.

Eurofins DiscoverX – new member

Eurofins DiscoverX develops and manufactures cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release and more. 

Fujifilm Diosynth – new international Member

Fujifilm Diosynth Biotechnologies focus is to combine technical leadership in cell culture, microbial fermentation, viral vectors and cell therapy with world class cGMP manufacturing facilities to advance tomorrow’s medicines in both the clinic and global commercial supply.

LEADS TO DEVELOPMENT – new member

LEADS TO DEVELOPMENT offers consultancy, regulatory advice and operational management for the preclinical and non-clinical development of therapeutic products, together with clinical oversight.

Biophysium – new member

Biophysium is an innovative bio-health company (CRO) specialized in the conception and realization of pre-clinical and clinical research services for cardiovascular health, metabolic diseases prevention and nutraceutical.

DeepLife – new member

DeepLife is an AI company building digital twins of cells to accelerate drug discovery with a large focus on understanding of the underlying mechanisms of action.

CytobodX – new member

CytobodX produce, purify and characterize soluble and membrane proteins using state-of-the-art technologies to meet the specific needs of your research.

Bioluminescence Imaging of the Brain

New tool for scientists studying conditions such as autism and Alzheimer’s disease, codeveloped by Promega R&D scientists, alongside co-authors from Stanford Medicine.

Discngine – new member

Discngine is a software and services provider for life sciences research organizations, assisting in the discovery of new molecules.

ExAdEx-Innov – new member

ExAdEx-Innov is a biotech company that gathers researchers, KOLs and clinicians with decades of experience and expertise in human adipose tissue biology and cell therapy applications to answer the unmet medical needs.

AzurBio Pharma – new member

AzurBio Pharma is a new international pharmaceutical company developing products and activities in the area of pharma innovation and rare or serious diseases.

Alga Biologics – new member

Alga Biologics is a blue biotech start-up specializing in the R&D, production and commercialization of anti-tumor antibodies produced from microalgae.

Ilonov – new member

Ilonov is a preclinical stage biotech developing first-in-class biologics against chronic metabolic diseases, harvesting the potential of muscle secretome to regulate metabolism, a novel & unexplored approach.

BioKryo France – new member

BioKryo France offers tailor-made storage solutions to all structures confronted with a need in the management or the storage of biological samples.

Evidentic – New International Member

Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.

CapEval Pharma – new member

CapEval Pharma provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance.

Ariana Pharma in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results from a post hoc analysis of CY6463 first-in-human studies at the 2022 Clinical Trials On Alzheimer’s Disease (CTAD)

Ariana Pharma, a leading Artificial Intelligence (AI) drug development company, in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results from a post hoc analysis of CY6463 first-in-human studies at the 2022 Clinical Trials On Alzheimer’s Disease (CTAD) international conference held in San Francisco, USA.

Smart Immune – new member

Smart Immune is a clinical-stage biotechnology company developing ProTcell™a thymus-empowered T-cell therapy platform to fully and rapidly re-arm the immune system, enabling next generation allogeneic T-cell therapies for all.

bYoRNA – new member

We are experts in RNA biology, design and implementation of bioproduction platforms for therapeutic products. Our disruptive technology uses eucaryotic cell biofactories to make high-quality messenger RNA (mRNAs).

ILife Consulting – new member

ILife Consulting is a clinical development partner with an entrepreneurial edge tailored for innovative, emerging life science companies.

Pierre Fabre; Atara: CHMP Recommends Approval of Atara Biotherapeutics’ EbvalloTM (tabelecleucel) for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease

Atara Biotherapeutics, Inc. and Pierre Fabre today announced the CHMP of the EMA has adopted a positive opinion recommending the EC approval of EbvalloTM (tabelecleucel) as a monotherapy for treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy.

Cherry Biotech – new member

Cherry Biotech is a world-class PharmaTech, French, helping pharma, biotech, and CRO in their preclinical 3D vascularized immuno-competent organoids.

HORIANA – new member

HORIANA is a consulting company dedicated to epidemiology and biostatistics, designing and conducting Healthcare Real-World Studies.

Plantibodies – new member

Plantibodies is a unique biotech company dedicated to the development and production of plant based monoclonal antibodies.

NeoBioSys – new member

Since 2009, NeoBioSys has been offering customized industrial microbiology solutions to meet our customers’ needs. We offer you all our expertise in the development and intensification of bioprocesses and production.

Allogenica – new member

Allogenica is a biotechnology company developing an allogenic “off-the-shelf” CAR-T cells bioproduction platform.

POLYGON Therapeutics – new member

POLYGON Therapeutics is a biotech in cardio-immunology that intends to improve cardiovascular care by targeting and regulating CVDs immuno-inflammatory responses.

Ondalys – new member

Expert in machine learning and process supervision, the Ondalys team supports pharma and biotech manufacturers in controlling and better understanding their products and processes.

INOTREM – new member

Inotrem is an advanced clinical stage biotech company specialized in immunotherapy to control dysregulated inflammatory reactions.

GenSensor – new member

GenSensor was founded with a vision to become a game changer in the field of genomic based in-line bioproduction monitoring.

Promepla – new member

Promepla is the specialist of design, development and manufacturing of single-use solutions for bioprocesses.

SEQALIS is a sponsor of the MabDesign Network

SEQALIS offers analytical and customized  R&D services in anatomo-pathology, cytogenetics and molecular biology (Next Gen Sequencing & PCR) to the biotech, pharma and more widely to the life sciences sector.

Covalab Lauréat de LabCom 2022

Le LabCom IAM-IT ( Laboratoire Commun d’Ingénierie des Anticorps Monoclonaux Innovants à visée Thérapeutique) porté par le laboratoire académique INSERM UMR1231 de Dr. Olivier MICHEAU de l’université Bourgogne Franche-Comté (UBFC) et la societé COVALAB dirigée par le Dr Said El Alaoui, sont parmi le 7 premiers Lauréats de l’appel à projets LabCom.

ErVaccine Technologies – new member

At ErVaccine Technologies S.A., a French biotech company incorporated in October 2019, we develop next-generation cancer vaccines and T-cell therapies.

NVH Medicinal – new member

NVH develops products based on recombinant proteins derived from collagen for applications in hemostasis and regenerative medicine.

Advanced Instruments – new member

Advanced Instruments is dedicated to increasing productivity and ensuring quality in the biotechnology, pharmaceutical, clinical and food & beverage industries.

Oncodesign – new member

Oncodesign is a leading biopharmaceutical company that meets the needs of innovation in the health industry through precision medicine.

IMAVITA – new member

IMAVITA is an innovating contract research organization (CRO) proposing preclinical services in the exploration of preclinical models of human pathologies

VIEWaves – new member

To help surgeons, we have developed innovative, stable and robust fluorescent molecules. They will be grafted onto antibodies that will specifically recognize tumor cells. These new molecules will emit intense light in the near-infrared range that will precisely identify the contours of the tumor. This light will guide surgeons in removing cancerous tumors.

Alter Ego Biotech – new member

We are CMC experts in bioprocess industrialization, we provide strategy setting up & operational support from pre-clinical stages to product commercialization.

SynHelix – new member

SynHelix team is devoted to the development of the most robust and scalable DNA synthesis technology using a specifically engineered high-perfomance enzyme

EuropaBio NAC Summit Report 2022

EuropaBio today published the National Associations Council (NAC) Summit 2022 Event Report ”Biotechnology on which MabDesign was also involved: Delivering Europe’s industrial strategy across the sectors”.

Appel à projets : « Industrialisation et Capacités Santé 2030 »

Appel à projets : « Industrialisation et Capacités Santé 2030 » vise à soutenir les projets d’industrialisation dans les secteurs de la biothérapie et bioproduction de thérapies innovantes, de la lutte contre les maladies infectieuses émergentes et les menaces NRBC, et des dispositifs médicaux et dispositifs de diagnostic in vitro.

Le consortium OPTI-STEM mené par la CDMO Cell-Easy reçoit un financement public de plus de 7 millions d’euros dans le cadre de la stratégie d’Accélération « Biothérapies et Bioproduction de thérapies innovantes »

Le projet OPTI-STEM vise à optimiser la production de CSM pour en démocratiser l’accès et permettre ainsi la diversification des applications thérapeutiques de ce type de cellules et de leurs dérivés (exosomes, etc.). Pour atteindre cet objectif, le consortium de R&D mené par Cell-Easy a obtenu un financement public de plus de 7 millions d’euros dans le cadre de la stratégie d’Accélération « Biothérapies et Bioproduction de thérapies innovantes », opérée pour le compte de l’Etat par Bpifrance.

CEVIDRA – new member

Cevidra is a family-owned and independent pharmaceutical company whose activity is based on the exploitation, distribution, manufacturing and importing of drugs in a single integrated process to support international companies to access the French market.

DIAGAST – new member

DIAGAST is committed at your side by developing automated systems always more adapted to your activity of Immuno-Haematology.

ATESSIA – new member

ATESSIA is a regulatory and pharmaceutical affairs consultancy specializing in the health industries.

Lumicks is a sponsor of the MabDesign Network

LUMICKS is a leading life science tools company that develops equipment for Dynamic Single-Molecule and Cell Avidity analysis, two rapidly emerging areas in biology research and immuno-oncology.

Appel à projets France 2030 : « Première Usine »

Dans le cadre du plan d’investissement France 2030, l’appel à projets « Première usine » vise à accélérer l’émergence de premières réussites d’industrialisation par des start-ups industrielles, ou PME /ETI innovantes.

Appel à projets : Concours d’innovation – i-Nov

L’appel à projets « Concours d’innovation i-Nov » est un dispositif de soutien financé par le Programme d’Investissements d’Avenir (PIA) qui a pour vocation de sélectionner des projets d’innovation au potentiel particulièrement fort pour l’économie française. La 9e vague du Concours est ouverte jusqu’au 22 mars 2022 à 12h (midi heure de Paris).

Mithra is a sponsor of the MabDesign Network

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause.

CLEMANN Group – new member

CLEMANN GROUP aims at offering to developers/innovative founders in Life Sciences its expertise in pharmaceutical development operations and industrial affairs.

Appel à projets : Innovations en biothérapies et bioproduction

L’appel à projets « Innovations en biothérapies et bioproduction » est un dispositif d’aide s’inscrivant dans le cadre de la stratégie d’accélération « Biothérapies et bioproduction de thérapies innovantes ». Il a pour objectif de catalyser et maintenir l’excellence de la recherche en biothérapie en accélérant notamment le transfert technologique et en assurant un flux constant d’innovations, de la paillasse au lit du patient.

Althekia – new member

ALTHEKIA supports healthcare companies in their clinical purchasing strategy to improve the sourcing process and optimize the project management.

IMABGEN Project, an innovative platform in immunotherapies

The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D Booster’’ 2021 program driven by the Region Auvergne-Rhône-Alpes.

System-C Bioprocess – new member

system-C Bioprocess is an expert, partner and distributor of reference brands, on the lookout for innovative technologies, our offer integrates all stages of bioprocesses.

Festo – new member

Festo, a global supplier of pneumatic and electrical automation technology, offers innovative solutions for medical technology and laboratory automation through its LifeTech division.

SMALTIS – new member

 SMALTIS is a laboratory specialized in microbiology delivering tailor-made solutions with high added value, to support the development of health products, from research to clinical steps.

AGILAE Qualie – new member

AGILAE Qualie est une société qui accompagne ses clients dans le développement et la mise en place des outils qualités et documents permettant la maitrise de la production de dispositifs médicaux et de composés pharmaceutiques tout au long du cycle de vie.

GreenTropism – new member

GreenTropism conceives Artificial Intelligence softwares to optimize production control processes for industries and OEM.

FILAB – new member

Based in Dijon, FILAB is a laboratory providing analytical chemistry services and expertise.

INDATECH – new member

INDATECH provides Innovative Optical Solutions for Process Development and Process Control.

Vetbiobank – new member

Vetbiobank develops neonatal stem cell-based cellular drugs with unique potential to fight  dogs, cats and horses’ chronic inflammatory diseases.

BE4S – new member

BE4S is a dedicated network of Experts and complementary competencies (preclinical R&D, management and business development) to bring your innovation to the success.

GTP Biologics – new member

GTP Biologics is a subsidiary of the Fareva group specialized in the development and GMP production of biological molecules (antibodies, recombinant proteins, ADC).

CliniSciences – new member

CliniSciences commercialises reagents (antibodies, recombinants, ELISA kits, RNAi, cDNA clones, probes, PCR/qPCR reagents…) to diagnostic and research labs.

Vaxxel – new member

Vaxxel develops the first intranasal live attenuated and multivalent viral vaccine against HMPV and HRSV .

VERDOT Ips² – new member

VERDOT Ips² provides its expertise in design and realization of purification equipment for several Biopharma projects and other industries, starting from the development phase to the industrial stage.

Ypso-Facto – new member

Ypso-Facto develop, optimize, and secure (bio)chemical processes with software tools and consulting services.

Waters – new member

Waters, the world’s leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years.

MabDesign dévoile sa feuille de route pour la période 2021-2025

MabDesign se dote d’une nouvelle gouvernance (ABL Europe, bioMérieux, DBV Technologies, Institut Pasteur, Lyonbiopôle, Pierre Fabre, Sanofi, Thermo Fisher Scientific, TreeFrog Therapeutics, Hervé Broly, Nicola Beltraminelli, Stéphane Legasteloi) qui lui permettra de mettre en œuvre une feuille de route ambitieuse pour accompagner son développement en matière de soutien à la filière industrielle française des biomédicaments.

Explicyte – new member

Explicyte provides innovative services to the pharmaceutical industry to support drug development programs with a translational offer combining both in-vitro / ex-vivo & in-vivo approaches.

Scailyte AG is a sponsor of the MabDesign Network

Scailyte AG is a spin-off of ETH Zurich and combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers, with a focus on oncology and immunology.

IPRASENSE – new member

IPRASENSE develops and commercializes innovative cell culture monitoring equipments from early biological research to biopharmaceutical industry and therapeutic molecule production.

AGS-M – new member

AGS-M develops cutting-edge processes for the mass production of microalgae extracellular vesicles (MEV) and produce GMP-grade batches of MEV.

AGS Therapeutics – new member

AGS Therapeutics engineers the billion-years-old natural machinery of microalgae to develop therapeutics (such as mRNA, RNAi, proteins, peptids, and more) delivered by microalgae extracellular vesicles.

MicroOmix – new member

MicroOmix develops and commercializes a “Single-Cell” analysis device for high-throughput screening and recovery of living cells according to their secretion profile.

Deeplink Medical – new member

Based in Lyon and created in 2014 by 5 radiologists, Deeplink Medical digitalizes medical imaging proposing platforms to optimize the patient pathway.

OP2 Drugs SAS – new member

OP2 Drugs SAS is a biotech company that aims at developing innovative life-saving drugs for unmet medical needs, especially in the cardiology field.

Keralia – new member

Keralia provides a cloud-based software platform, newLab, to automate and digitalize R&D workflows, from the lab to pilots of new products.

I&L Biosystems – new member

I&L Biosystems offers innovative solutions for research in life sciences, cell culture, purification processes, bioproduction and microbiological controls.

Domain Therapeutics – new member

Domain Therapeutics is a BioPharma company committed to improving the lives of patients by providing cancer immunotherapies and innovative treatments for neurological disorders and rare diseases.

MGA Technologies – new member

MGA Technologies is specialized in the design and assembly of custom-made machines for the most restrictive industrial environments.

Deeptope – new member

Through our self-developed in vitro methods of efficient PARATOPE/EPITOPE MAPPING and antibody LEAD OPTIMIZATION, Deeptope can greatly improve your antibody development timelines and outcomes.

OCR – new member

OCR is specialized (1) in Comparative Medicine studies with Drug/MedTech candidates Human health (2) the design and the monitoring of Pilot & Pivotal Clinical Studies of Dogs/Cats for the Vet market and (3) non-GLP preclinical histology/IHC.

Conectus – nouveau membre

SATT Conectus

Conectus rapproche les laboratoires de la recherche publique alsacienne et les entreprises, pour multiplier les collaborations entre ces deux mondes et dynamiser ainsi l’innovation française.

Cepheid – new member

Cepheid is striving to deliver the benefits of seamlessly accessible molecular testing closer to the patients.

Schrödinger is a Sponsor of the MabDesign Network

Schrödinger supports the MabDesign Network. Schrödinger is the scientific leader in computational chemistry, providing software solutions and services for life science and materials science research, as well as enterprise-level software platforms.

PhinC Development – new member

PhinC Development is the expert partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research.

ACS Biotech – new member

ACS Biotech is an innovative start up in biotechnology. Created in 2013, we develop tissue repair solutions based on natural polymers such as chitosan.

BioAgilytix is a Sponsor of the MabDesign Network

BioAgilytix supports the MabDesign Network. BioAgilytix’s global team of highly experienced scientific and QA professionals deliver world-leading science, proven data integrity, and deep regulatory expertise to support all phases of large molecule global studies.

Tridek-One – new member

Tridek-One is a biotechnology company focused on developing first in class immunomodulatory products targeting the CD31 pathway.

MabDesign recrute un(e) Développeur Full Stack Web

  Contexte MabDesign est une association créée en novembre 2014 qui vise à structurer et animer la filière industrielle française des biomédicaments. L’association est soutenue par BPI France dans le cadre d’un appel « Filières Industrielles Stratégiques » issu du Programme Investissements d’Avenir. Fin 2020, MabDesign a démontré sa capacité à être autofinancée grâce à […]

C.RIS Pharma – new member

C.RIS Pharma is a french Contract Research Organization (CRO), GLP certified, specialized in preclinical development of new active molecules against human diseases.

Urodelia – new member

Urodelia is a biotech company based in France, specialized in calcium phosphates chemistry and more precisely hydroxyapatite.

ImmunXperts is a Sponsor of the MabDesign Network

ImmunXperts, a Q2 Solutions Company is a Sponsor of the MabDesign Network. It offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment or by saving time and money through custom assay development.

New England Biolabs – nouveau membre

New England Biolabs France

La coopérative scientifique New England Biolabs, société privée américaine, est leader mondial pour la production et la distribution de réactifs destinés à la recherche en science de la vie.

MadeCELL – new member

 MadeCELL provides the latest production & quality software dedicated to cell, gene and tissue therapy production centers.

Institut Pasteur – new member

The Institut Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.

Le Campus Biotech Digital s’allie aux écoles et organismes de formation en biotechnologie pour développer les talents de demain

Le Campus Biotech Digital, piloté par un consortium industriel de premier plan (bioMérieux, Novasep, Sanofi, Servier), s’allie à un panel d’acteurs incontournables de la formation en biotechnologie : EASE, l’ENSTBB-Bordeaux INP, l’ESTBB, IFIS, le Groupe IMT, MabDesign, Sup’Biotech. Ces écoles et organismes de formation vont accompagner le Campus dans l’élaboration de ses parcours pédagogiques comprenant des modules de formation digitaux, à destination des salariés du secteur ou en reconversion, des étudiants et des demandeurs d’emploi.

McSAF obtained a patent for DAR 4 antibody-drug conjugates technology

The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside® technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.

MedXCell NKar – new member

 MedXCell NKar is a French Life Science company active in the field of immunotherapy. It is specialized in the development of therapeutic solutions combining Natural Killer (NK) cells and monoclonal antibodies.

RD-Biotech lauréate de l’appel à projet France Relance

RD-BIOTECH, voit son projet de construction d’une unité de production « Plasmides GMP » sélectionné par l’Etat comme lauréat de l’appel à projet « AAP Plan de relance pour l’industrie- Secteurs stratégiques » dans le cadre de France Relance.

Bio-Europe Spring 2021 – Support en Business Development

MabDesign est partenaire du salon de partnering international BIO-Europe Spring, du 22 au 25 mars 2021 au format Digital, qui rassemblera plus de  2 500 dirigeants de sociétés biotechnologiques, pharmaceutiques et financières du monde entier. MabDesign mets en place un support en Business Dévelopment pour vous aider a trouver les prospects qui vous correspondent lors de ce RDV unique internationale.

MedinCell – new member

MedinCell is a clinical stage drug delivery company whose ambition is to make better and affordable medicines through the design of long-acting injectables.

Indena – new member

Indena is the leading company dedicated to the identification, development and production of high quality active principles derived from plants, for use in the pharmaceutical and health food industries.

EverZom – new member

 EVerZom is an exosome company developping a GMP compatible large scale manufacturing platform for exosome therapeutics.

Gyros Protein Technologies – new member

Gyros Protein Technologies provides enabling bioanalytical and peptide synthesis solutions that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications

LinBox – nouveau membre

Société de conservation de produits d’origine humaine à des fins de recherches ou thérapeutiques, sous autorisation de l’ANSM.

CYBERNANO – new member

CYBERNANO is a Contract Research Organization in Biostatistics for Risk Assessment and Quality Optimization.

Phost’in Therapeutics – new member

Phost’in’s creation is the concretization of ten years of academic work performed by a consortium of academic researchers in Montpellier and Paris, led by Prs. Norbert Bakalara, Jean-Luc Pirat and David Vireux.

XEGEN – new member

XEGEN is a bioinformatic company specialized in NGS « Next Generation Sequencing » data analysis.

Honing Biosciences – new member

Honing Biosciences is a bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases.

G.CLIPS biotech – new member

G.CLIPS biotech created the first quick decision tool for membrane proteins environment and conformation stabilization.

Carla DA COSTA nommée Directrice Générale de CREAPHARM GROUP

23 Juin 2020 – Eric Placet, Président de CREAPHARM GROUP annonce la nomination de Carla Da Costa en qualité de Directrice Générale à compter du 16 juin 2020. Business Development Director et membre du Comité Exécutif du groupe, Carla Da Costa accompagne Eric Placet depuis 2013. En savoir plus

AIOVA – new member

AIOVA est une jeune biotech qui développe des vaccins innovants pour protéger les hommes et les animaux contre des maladies non traitées par les vaccins traditionnels (de type SIDA, Grippes, …) .

FUJIFILM Irvine Scientific – new member

FUJIFILM Irvine Scientific is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the production of biotherapeutics.

Cell-Easy – new member

Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.

Carroucell – new member

Carroucell développe des microporteurs et matrices en verre bio-actif pour la culture cellulaire 3D et en bioréacteur.

Naobios – New member

Acteur du secteur des Biotechnologies, la société NAOBIOS (une société du groupe Clean Biologics) a pour mission de développer des procédés de production de vaccins ou vecteurs viraux et de produire du matériel destiné à l’expérimentation préclinique et clinique pour des tiers.

Endress+Hauser Process Analysis Support – new member

Endress+Hauser Process Analysis Support Europe is dedicated to provide complete analytical solutions with the integration of laser based technologies such as Kaiser Raman spectroscopy and SpectraSensors TDLAS for real-time monitoring of chemical composition from laboratory to process applications.

Gencovery – new member

GENCOVERY is specialized in the development of AI software and digital twins of living organisms to optimize the bioproduction processes of biotech and pharma companies.

Animal Immune Company – new member

Production de cytokines autologues pour moduler la réponse immunitaire en vu de réparer les lésions des chevaux présentant des pathologies chroniques et en particulier de l’asthme et de l’arthrose.

Venn Life Sciences – new member

Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of pre-clinical and CMC drug development expertise, clinical trial design and management.

Oz Biosciences – New member

OZ Biosciences provides rising generations of research reagents based on molecular delivery systems to serve and assist the life science community in its mission.

Emergence Therapeutics – nouveau membre

EMERGENCE Therapeutics

Emergence Therapeutics est une société fonctionnant en mode virtuel et qui est dédiée au développement de conjugués anticorps-médicaments (ADC) de nouvelles générations pour le traitement de pathologies cancéreuses avec un fort besoin thérapeutique non satisfait.

Axelys Santé – new member

Axelys Santé is a full services Contract Research Organization which supports healthcare and biotech industries by providing high-level expertise and innovative solutions to issues related to healthcare product development process of your drug/ device from the idea to the market access.

EUROGENTEC – new member

 Eurogentec is a 30+ years biotech providing solutions in genomics (oligos, qPCR) and proteomics (peptides, antibodies, assay kits) to the research and diagnostic communities, and a CDMO for the bio-production of pharmaceuticals (vaccines and medicines).

VECT-HORUS – new member

VECT-HORUS designs and develops vectors to facilitate the targeted delivery of drugs or imaging agents into the brain and other organs.

Miltenyi Biotec – new member

For almost 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

NBS Scientific – new member

NBS Scientific is a distribution company providing innovative solutions for biobanks, research centres and other laboratories in the life science industry.

ImCheck Therapeutics – new member

 ImCheck Therapeutics is driving innovation in two powerful new areas of immune system modulation: the butyrophilins superfamily of immunomodulatory molecules and gamma-delta T cells.

CovalX Analytics – new member

CovalX provides high-quality analysis of protein interactions, antibodies, and therapeutic protein aggregates by mass spectrometry.

ImmThera Consulting – new member

ImmThera Consulting has been created in Jan 2018 (CIR accredited) based on 22+y of intl R&D experience in immunotherapeutics/vaccines in cancer & chronic diseases.

PIGASE – nouveau membre

PIGASE

PIGASE est une CRO indépendante pour étude préclinique et production d’anticorps sur animaux de rente

LI-COR – new member

 LI-COR technology enables scientists around the world to improve lives by advancing discovery.

Kunher Shaker – new member

From bench top shakers to large industrial shakers, Kuhner AG manufactures high quality machines for customers around the world.

PharMarketing – new member

PharMarketing is an operational consulting company based in France and acting in Europe an. We help organisations in Life Sciences to comply with Data Privacy, GxP, and IT Best Practices.

4th edition Bioproduction of Immunotherapies

The 4th edition of the Bioproduction of Immunotherapies co-organized by MabDesign and Medicen Paris Region took place at Biocitech on September 24th 2019.This growing event gathered together more than 130 participants from over 90 companies to discuss and learn more about the latest innovations on the Immunotherapies Bioproduction.

Alhena Consult – new member

Alhena Consult supports you throughout the development cycle of your products including registration and post MAA activities – whether you are a start-up or a large, established pharma company.

Stark Labs – new member

Stark Labs is a research & development company that focuses on therapeutic strategies against ageing and accumulation of senescent cells.

Chemometec – new member

ChemoMetec is a Danish founded company specializing in the development, manufacturing and sales of high-quality automated Cell Counters, Advanced Cell Analyzers and Image Cytometers.

Miliza Diab Consulting – nouveau membre

Miliza Diab Consulting

Miliza Diab Consulting et une entreprise qui fournit des services en conseil et en accompagnement des sociétés de biotechnologies dans la bioproduction de leur protéines recombinantes, des phases R&D au développement pré-clinique.

Pall Biotech – new member

Pall Biotech, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs.

SAFAS – new member

SAFAS designs and manufactures high technology scientific instruments since 1952.

ACOBIOM – new member

ACOBIOM is a French biotech company specialized in the discovery of new biomarkers and the development of predictive diagnostics tests.

4Clinics – new member

4Clinics is a Contract Research Organization providing Data management, Biostatistics, Medical Writing, Regulatory Affairs and Clinical Operations services for clinical, observational and epidemiological studies.

Myriade – new member

Resulting from the work of the Langevin Institute, a laboratory specialized in optical and ultrasonic technologies for the life sciences, the company Myriade, created in 2017 and based in Paris, markets Videodrop an imaging device based on a single-arm interferometric technique.

Keyrus Biopharma – new member

Keyrus Biopharma is a European Contract Research Organization (CRO) covering all the technical range of services for clinical research.

NOCOLEM – new member

NOCOLEM supports in the design and management of multiple aspects of “drug development”.

7th Antibody Industrial Symposium AIS2019

The 7th edition of the Antibody Industrial Symposium AIS2019 was held on June 24th & 25th 2019 in the Vinci International Convention Centre of Tours.This growing event was this year dedicated to “Harnessing the Immune System with Therapeutic Antibodies” major theme chosen by the Scientific Advisory Board. The AIS2019 allowed to gather +350 attendees from start-ups, SME, big industrials & academics based in more than 15 different countries with the will to exchange and make advance the therapeutic antibody field.

Immune InsighT – new member

Immune InsighT is a CRO that offers unique expertise in ex-vivo and in-vivo assessment of drug candidates in the fields of cancer, autoimmune and inflammatory diseases on the immune system and notably on regulatory T cells (Tregs).

Ariana Pharma – new member

Ariana’s KEM® Artificial Intelligence platform enables to fast track Drug Development implementing patient stratification for precision medicine.

KDBIO – new member

KDBIO sells and supports : 1) FiberCell Hollow Fibre Bioreactor – very concentrated monoclonal antibodies or other cell-secreted products can be harvested from cells in continuous culture 2) automated remote glucose/lactate sensors and control systems (C-CIT AG).

Cytune Pharma – new member

Cytune Pharma is a biotech company dedicated to the research and development of a portfolio of novel immunotherapeutic agents.

TreeFrog Therapeutics – new member

TreeFrog Therapeutics (TFT) is a Stem Cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues.

XENOTHERA – new member

XENOTHERA is a biotechnology start-up company at the top of innovation, which creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases.

SOPHiA Genetics – new member

SOPHiA GENETICS offers clinical-grade genomic solutions to help experts accurately detect and characterize genomic variants associated with cancers and hereditary disorders.

MABDESIGN and REGIMBEAU announce strategic partnership

 MABDESIGN has signed a partnership agreement with REGIMBEAU, an intellectual property law firm. This new agreement, in line with MABDESIGN’s strategy to expand its range of business support services, will allow the organization to propose a one-stop-shop offer across all intellectual property domains as applied to biopharmaceuticals.

SGS France, Life Science Services – new member

SGS France, Life Science Services – Saint-Benoit laboratory provides bioanalytical services for both Small and Large Molecules, including Mass Spectrometry, Immunoassays and Cell-Based Assays services.

SKYMAB Biotherapeutics – new member

Skymab Biotherapeutics is a CEA spin-off biotech company committed to the design, engineering and development of antibodies targeting G Protein Coupled Receptors (GPCR) with a main focus in oncology.

Lymphobank – nouveau membre

Lymphobank est une biotech spécialisée dans la cession de cellules sanguines adultes et placentaires à usage recherche, issues de donneurs volontaires sains, dont les caractéristiques phénotypiques et fonctionnelles sont disponibles en ligne.

Daicel Bioseparations – new member

At Daicel Bioseparations we focus on providing our customers innovative separation and purification solutions for biomolecules in bioprocessing, biotech analytical and sample preparation applications.

INO Specimens BioBank – nouveau membre

INO Specimens BioBank

En collaboration avec le Groupe INOVIE, 350 Laboratoires de Biologie Médicale, INO Specimens BioBank, ISB, source les échantillons biologiques nécessaires à R&D, Production, CQ, Validation et Enregistrement réactifs/ instruments, pour les IVD, Pharma, CRO, Biotech.

ProfileHIT – new member

Through an innovative approach, ProfileHIT brings an early access to the biological potential of new molecules.

Biodoo – new member

Biodoo is a unique all-in-one software solution for research teams in Biologics and Protein Science.

PathoQuest – new member

PathoQues is a life sciences company offering a game changing metagenomics approach to improving pathogen detection in biological samples.

Early Drug Development Group – new member

Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.

PX’THERAPEUTICS DEVELOPS ITS SERVICES OFFER

PX’Therapeutics, a French pioneer in the production of customized recombinant proteins, offers custom-made protein production for academic laboratories, companies and start-up that require quality proteins to perform preliminary studies (in-vitro/in-vivo).

Perkin Elmer – new member

Partner with PerkinElmer to enhance and streamline your biotherapeutics workflow from target discovery to manufacturing and quality control.

HEPHAISTOS Pharma – New member

HEPHAISTOS Pharma is a preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers.

Peptinov – new member

Peptinov is a privately held biotechnology company focused on the development of peptide-based immunotherapies targeting self-proteins, for the treatment of chronic inflammatory diseases and cancers.

AlteVax – new member

AlteVax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases.

Genopole – new member

Genopole, France’s leading biocluster for biotechnologies and research in genomics and genetics, unites innovative high-tech life sciences companies, public and private research and higher education facilities at a single site.

Bilan des Master Classes de l’immunothérapie 2018

La première édition des Master Classes de l’immunothérapie a eu lieu à Tours les 1er et 2 octobre 2018, au Bio3 Institute. L’évènement-formation a été co-organisé par MabDesign, le Groupe IMT et le LabEx MAbImprove. Cette première a réuni plus de 60 personnes issues de startup, sociétés de biotechnologies, groupes pharmaceutiques et structures académiques, parmi […]

SCIEX- new member

SCIEX has a longstanding track record in helping scientists in pharma discovery, development and manufacturing to transform pipeline capacity and capability through the adoption of CE and LC-MS technologies.

AIS2018 – The mAbs Event in France !

The 6th edition of the Antibody Industrial Symposium (AIS2018) co-organized by MabDesign and the LabEx MAbImprove took place at the Corum Conference Center in Montpellier from June 25th to June 26th 2018.
The AIS2018 Congress gathered more than 250 participants from over 120 companies based in 11 different countries to discuss and learn about the latest innovations on Targets for MAbs and innovative approaches for their Discovery & Validation.

TALIX Therapeutics – new member

TALIX Therapeutics, is a privately-held biotech company pioneering the next generation of immune modulators with a diversified portofolio of first-in-class therapeutic antibodies in cancers.

GenoSafe – new member

GenoSafe® is a full contract research and consulting organization which specializes in evaluating the quality, safety and efficacy of innovative biological products.

Precision for Medicine – new member

Specialized in oncology and rare diseases, Precision for Medicine supports the discovery, development, clinical trial work, and implementation of biomarkers essential for targeting patients more precisely and effectively.

Odimma – new member

Odimma has for mission to bring a sustainable diagnostic and therapeutic solution in oncology adapted to each patient.

SEEKYO – new member

SEEKYO® provide solutions to enhance the therapeutic efficacy of anticancer drugs.

BIOTRIAL – new member

Biotrial is a full service CRO with 30 years of experience in Non-Clinical to Clinical Research.

ICTA – new member

ICTA is an international leading CRO providing full-service solutions or stand-alone services

Horiba Scientific – new member

HORIBA Scientific offerings encompass elemental analysis, molecular spectroscopy, surface science and particle sizing instrumentation.

iMAb – nouveau membre

iMAb est une société de services qui fournit des anticorps monoclonaux humains, ou fragments ou produits dérivés de ces anticorps.

Theradiag – nouveau membre

THERADIAG

Forte de son expertise dans le développement et la fabrication de tests de diagnostic in vitro,Theradiag innove et développe des tests de théranostic.

e-Zyvec – new member

We provide an integrated service for design and production of tailor-made DNA vectors.

BIO ELPIDA – new member

Founded in 2009, Bio Elpida is a Biotechnology Contract Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

Purolite – new member

For over 35 years, Purolite has supplied specialty ion exchange resin technology to industries.

Sartorius Stedim Biotech – new member

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry.

ENCEFA – new member

ENCEFA is a biopharmaceutical company issued from the “Brain and Spine institute” (ICM) Labs.

Clean Cells, a partner in an innovative project: “HybridADCC”

Clean Cells and its partners – OSE Immunotherapeutics SA, INSERM UMR1232/CNRSERL6001, the MicroPiCell platform– have been granted with a €2,4M funding from the Fonds Unique Interministériel (FUI – cofunding from BpiFrance & the Pays de la Loire region) for a 36-month innovative project: “HybridADCC”.

I4ID2017 Congress- a great success !

The “I4ID 2017”, the first international congress dedicated to immunotherapies for infectious diseases to take place in France, was a real success.

ABCell-BIO – new member

ABCell-Bio team has been offering its bio-expertise in fields as complex as Hematopoiesis, Vascular Biology, and Tissue Regeneration.

XENTECH – new member

XenTech is a Biotech Company developing a pre-clinical platform for translational research in oncology.

ALTRABIO – new member

AltraBio is an R&D company expert in analysis and interpretation of biomedical data in both preclinical and clinical development.

2e édition Bioproduction des Immunothérapies en France

La 2e édition Bioproduction des Immunothérapies co-organisée par MabDesign et Medicen Paris Région en partenariat avec France Biotech a rassemblée plus de 120 participants issus de plus de 70 sociétés, start-ups, PME, grand groupes, académiques et cliniciens travaillant sur la filière de l’immunothérapie en France.

IMEBIO – nouveau membre

IMEBIO

IMeBIO est un Bureau d’Etude, concepteur et fabricant de laboratoires de Biosécurité (dits BSL2 et BSL3) construits en containers transportables.

Ceva Santé Animale – nouveau membre

Laboratoire vétérinaire, nos activités se concentrent autour de la recherche, le développement, la fabrication, la commercialisation et le marketing de produits pharmaceutiques et vaccins pour les animaux.

H-Immune – new member

H-Immune develops novel fully human antibody-based therapeutics with a strong focus on immuno-oncology.

YPOSKESI – nouveau membre

Yposkesi est un établissement pharmaceutique français dédié à la production de médicaments de thérapie génique et cellulaire pour les maladies rares.

AIS2017-The ADCs Event in France !

For the fifth time the Antibody Industrial Symposium (AIS2017), organized this year by MabDesign, Polepharma and the LabEx MAbImprove, brought together almost 300 participants.

Phylogene – new member

Our company is a service and R&D company in genomics, transcriptomics, proteomics, metabolomics and dedicated bioinformatics.

OSIVAX- new member

OSIVAX

OSIVAX is a biotech start-up based in Lyon (France) and focused on vaccines.

Ciloa – new member

Ciloa

Ciloa is a biotechnology company created in 2011 that develops a new generation of preventive and therapeutic vaccines based on the production of major medical targets on exosomes. Ciloa is a spin-off of the CNRS and the University of Montpellier.

QUIID – new member

QUIID

At QUIID we design innovative bio-informatics solutions that extract patterns from omics data.
Our data mining solutions are used by scientists during (pre-)clinical studies, drug design and translational research activities.
All our innovations are published as POCs in peer-review journals.

AmatsiGroup – new member

Amatsigroup is a leading international Contract Development and Manufacturing Organization, headquartered in France.
We provide high-quality, customized and cost-effective drug development solutions, integrated under one roof, to small biotech and major (bio) pharmaceutical customers.

Agro-bio – new member

Agro-Bio

Agro-Bio offers various biotechnological solutions and specific high quality products. Agro-Bio’s fields of activity concentrate on immunotechnology, protein biochemistry and platelet aggregation.

MabDesign recrute son Responsable Business Intelligence

MabDesign recrute son Responsable Business Intelligence.
Sous la responsabilité du Directeur des Opérations, localisé à Lyon, le Responsable
Business Intelligence sera en charge de la création, de la promotion et de la réalisation des services de business
intelligence aux entreprises de la filière, en lien avec le reste de l’équipe MabDesign localisée à Lyon et en lien
avec la coordination des programmes MAbImprove et ARD2020 Biomédicaments.

3D Matrix – new member

3-D Matrix Europe SAS

3-D Matrix develops and manufactures a family of self-assembling peptide for use in clinical applications as medical devices in 3 main areas: surgery, tissue regeneration, drug delivery. 3-D Matrix recently obtained the CE marking for using PuraStat® as a hemostat in surgery.

Nanobiose – new member

Nanobiose offers solutions to assess the immunological safety of innovative health products such as nano-drugs, biologicals, nanoparticles used in the formulation of vaccines, vectors, dermo-cosmetic products or implantable medical devices.

MabDesign recrute son Responsable Business Intelligence

MabDesign recrute son Responsable Business Intelligence.
Sous la responsabilité du Directeur des Opérations, localisé à Lyon, le Responsable
Business Intelligence sera en charge de la création, de la promotion et de la réalisation des services de business
intelligence aux entreprises de la filière, en lien avec le reste de l’équipe MabDesign localisée à Lyon et en lien
avec la coordination des programmes MAbImprove et ARD2020 Biomédicaments.

Indicia Production – new member

Indicia Production is a CMO specialized in the formulation and aseptic filling of excipients, culture media and saline solutions for the pharmaceutical industry.

Oncofactory – new member

OncoFactory’s aim is to design innovative solutions to accelerate the development of precision medicine and personalization of oncology treatments.

HIFIBIO – new member

HIFIBIO

Research and preclinical development for the discovery of therapeutic molecules as well as the commercialization of the technologies associated with their discovery.

Thermo Fisher – new member

ThermoFisher Scientific (Life Technologies SAS)

ThermoFisher Scientific is the world leader in serving science with innovative technologies, purchasing convenience and comprehensive support. We help our customers accelerate life science research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Texcell – new member

Texcell is an international CRO dedicated to providing GCLP/GLP/GMP Immunology and biosafety services to support biopharmaceuticals’ development. We are committed to providing to our partners a flexible and customized service based on our 29 years of expertise.

Erytech – new member

Founded in Lyon in 2004, ERYTECH is a clinical-stage biopharmaceutical company that develops innovative therapies to fight rare forms of cancer and orphan diseases.

TxCell – new member

TxCell is a biotechnology company that develops innovative personalized T cell immunotherapy platforms for the treatment of severe inflammatory and autoimmune diseases with a high unmet medical needs.

ProteoGenix – new member

ProteoGenix is a leading French biotech company providing one stop solutions from Gene to biotherapeutics and diagnostics.

Diaclone – new member

Since more than 30 years, Diaclone develops monoclonal antibodies and immuno-analysis kits, with specificities in immunology, inflammation and apoptosis.

Carbogen AMCIS – new member

CARBOGEN AMCIS SAS offers a comprehensive range of services for the development and for contract manufacturing of sterile lyophilized and liquid dosage forms for New Molecular Entities (NMEs).

Antibody-Drug Conjugates Report 2016

Le Comité d’Orientation Stratégique et Scientifique de Filière (COSSF) de MabDesign se réunit plusieurs fois par an pour échanger sur les thèmes majeurs faisant l’actualité de la filière de l’immunothérapie …

Promega France – new member

Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial setting.

PETAL – nouveau membre

PETAL

PETAL, Promega Europe Training and Application Lab est le centre européen d’applications de Promega.

ABL EUROPE – nouveau membre

Du développement à la mise sur le marché ABL Europe fournit des vecteurs viraux GMP contribuant au succès des immunothérapies innovantes de ses clients.

ENSTBB – nouveau membre

ENSTBB – Bordeaux INP est une école d’ingénieurs et un centre de formation continue en biotechnologies.

GamaMabs Pharma – new member

GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.

Why Share Your Biosimilars Cake?

Biosimilar drugmakers should remember that the best cake – and the best biosimilar – is one that you don’t have to share with competitors.

Retour sur la formation continue : le Target Product Profile

Les 23 novembre et 07 décembre, respectivement à Lyon et à Paris, s’est tenue la formation “Target Product Profile : un outil stratégique pour améliorer la robustesse des projets de développement des anticorps thérapeutiques”.

LXRepair – nouveau membre

LXRepair développe des tests pour l’identification de biomarqueurs prédictifs de réponses aux thérapies anticancéreuses, basés sur la caractérisation fonctionnelle du réseau réparation de l’ADN.

ABL Lyon

ABL Lyon est une société prestataire de services pour le développement de tests immunologiques.

tebu-bio – new member

tebu-bio provides tailored and scalable lab services for the design and expression of protein variants & mAbs and their characterization.

C.RIS Pharma – new member

C.RIS Pharma is a Contract Research Organization (CRO) specialized in the preclinical evaluation of efficacy and toxicology (GLP) of new therapies.

Retrouvez MabDesign dans les prochaines conférences

MabDesign sera présent aux prochaines conférences :
Bioproduction Congress – Dublin, 19-20 Oct. 2016 – en savoir plus
Immunogenicty and Tolerance – Amsterdam, 24 Oct. 2016 – en savoir plus
PEGS Europe – Lisbon, 31 Oct.- 4 Nov. 2016 – en savoir plus
BIO-Europe – Cologne, 7-9 Nov. 2016 – en savoir plus
European Antibody Congress – Basel, 14-16 Nov. 2016 – en savoir plus

Fab’entech – new member

Fab’entech is a biopharmaceutical company which develops, produces and commercializes a range of anti-infective passive immunotherapy solutions.

EIVATECH

Eivatech propose des prestations à façon d’isolement d’anticorps de lamas monocaténaires (nanobodies ou VHH) dans un format recombinant.

FDA accepts sBLA to MSD’s KEYTRUDA® (pembrolizumab)

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab).

Novasep nomme le Dr. François D’Hooge au poste de Responsable de l’unité de bio-conjugaison

Novasep, un fournisseur leader de services et technologies pour les industries des sciences de la vie, annonce aujourd’hui la nomination du Dr. François D’Hooge au poste de Responsable de l’unité de bio-conjugaison. A ce poste, il pilotera la nouvelle usine de production d’anticorps monoclonaux conjugués (ADC – Antibody Drug Conjugates) sur le site du Mans, en cours de finalisation.

Formation Target Product Profile (TPP)

Développé à l’origine par la FDA, le Target Product Profile (TPP) est un outil stratégique pour améliorer la robustesse et le succès des projets de recherche et développement des anticorps thérapeutiques, largement utilisé par les biopharmas pour piloter les différentes étapes d’un projet de développement d’un biomédicament.

Cette journée vise à permettre à l’ensemble des acteurs industriels et académiques de comprendre les enjeux et les risques liés à la mise au point d’un anticorps thérapeutique et d’acquérir un langage commun facilitant les échanges et les collaborations.

Offre BIO EUROPE 2016

MabDesign sera présent au salon BIO-EUROPE 2016 qui aura lieu du 7 au 9 Novembre 2016 à Cologne (Allemagne).
Nous pouvons présenter votre offre et réaliser des rendez-vous pour vous ! Pour plus de détails sur cette prestation n’hésitez pas à nous contacter !

Phase III study shows promising results on Genentech TECENTRIQ (Atezolizumab)

Genentech, today announced positive results for TECENTRIQ from the Phase III study, OAK. The study met its co-primary endpoints and showed a statistically significant and clinically meaningful improvement in overall survival (OS) compared with docetaxel chemotherapy in people with locally advanced or metastatic non-small cell lung cancer (NSCLC).

​Sanofi et Regeneron présentent des données expérimentales positives de Phase III sur Praluent® (alirocumab), au Congrès 2016 de l’ESC

SANOFI

Sanofi et Regeneron Pharmaceuticals, Inc. annoncent aujourd’hui la présentation des résultats positifs détaillés de l’essai ODYSSEY ESCAPE de phase III ayant évalué Praluent® (alirocumab), solution injectable, chez des patients atteints d’une forme génétique d’hypercholestérolémie ou hypercholestérolémie familiale hétérozygote (HeFH).

MaaT Pharma

MaaT Pharma

MaaT Pharma est une start-up en biotechnologie créée fin 2014 pour traiter les maladies graves liées aux déséquilibres du microbiome intestinal. Elle développe la première solution de traitement qui s’appuie sur la microbiothérapie autologue. MaaT Pharma envisage une première application thérapeutique à destination des patients atteints de leucémie et d’infections ostéoarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.

PROTEODYNAMICS

La société PROTEODYNAMICS, fondée en 2005, est une société prestataire de services experte en caractérisation analytique des protéines et d’autres biomolécules, durant les phases de Recherche et Développement. Depuis sa création, PROTEODYNAMICS a déjà réalisé plusieurs centaines de projets à l’international concernant plusieurs milliers de protéines recombinantes ou natives pour des sociétés de biotechnologie, pharmaceutiques, […]

Pierre Fabre Médicament et Grupo Biotoscana signent un accord de commercialisation dans le domaine de l’oncologie

Pierre Fabre Médicament, deuxième laboratoire pharmaceutique privé français, et Grupo Biotoscana SL (GBT), importante société pharmaceutique spécialisée d’Amérique Latine, ont signé aujourd’hui un accord de commercialisation dans le domaine de l’oncologie. Selon les termes de cet accord, GBT commercialisera Navelbine® (Vinorelbine) sous ses formes injectable et orale, Javlor® (Vinflunine) et Busilvex® (Busulfan) en Colombie, au Chili, en Équateur et au Pérou.

GENEPEP

GENEPEP

Genepep is over 13 years old French company specialized in chemical synthesis of peptides, large peptide libraries and small proteins for therapeutic, diagnostic and cosmetic applications. Well-equipped in state of the art instruments, we specialize in non-GMP solution and solid phase peptide synthesis for research grade. We are able to provide solutions for all kind […]

OSE Immunotherapeutics présente des nouveaux résultats précliniques d’efficacité avec Effi-DEM

OSE Immunotherapeutics SA, société de biotechnologie qui développe des imunothérapies d’activation ou de régulation en immuno-oncologie, dans les maladies auto-immunes et les transplantations, annonce la présentation de trois posters au congrès de l’Association européenne de Recherche sur le Cancer (“European Association Cancer Research”) qui s’est tenu à Manchester du 9 au 12 juillet 2016. Ces posters portent sur des résultats significatifs d’efficacité dans des études précliniques en immuno-oncologie menées avec Effi-DEM, checkpoint inhibiteur de nouvelle génération.

Belgique: acquisition de CAF DCF par le LFB

LFB Biotechnologies

Aux termes d’un accord signé le 1er juillet 2016 entre LFB S.A., groupe pharmaceutique français, et Sanquin, la fondation néerlandaise en charge de l’approvisionnement en produits sanguins, le LFB a acquis l’entreprise belge CAF-DCF. L’accord signé inclut la commercialisation en Belgique des médicaments qui sont issus du plasma collecté par la Croix Rouge de Belgique.

4th Antibody Industrial Symposium 2016

Two day conference fully dedicated to therapeutic antibody and immunotherapy fields co-organized by MAbImprove and MabDesign.
More than 270 participants attended the 4th Antibody Industrial Symposium. More than 250 BtoB meetings took place at the meeting.

Nouvelle présidence pour le centre de Bioproduction Accinov

Trois ans après sa création, Accinov, la plateforme unique en Europe en matière de développement de projets biotechnologiques aux normes GMP, a procédé au renouvellement de son Conseil d’Administration lors de son Assemblée Générale du 30 juin 2016. André Dupont, Pharmacien Responsable d’Accinov SAS a été élu Président de cette organisation pour 3 ans. A […]

​Sanofi et Regeneron annoncent l’approbation au Japon de Praluent® (alirocumab) dans le traitement de l’hypercholestérolémie

SANOFI

Sanofi et Regeneron Pharmaceuticals, Inc. annoncent aujourd’hui que le ministère japonais de la Santé, du Travail et de la Protection sociale a délivré l’autorisation de fabrication et de mise sur le marché de Praluent® (alirocumab) dans le traitement de l’hypercholestérolémie à lipoprotéines de faible densité (LDL-C) non contrôlée chez certains patients adultes atteints d’hypercholestérolémie, à haut risque cardiovasculaire.

Webinar- CE methods for mAbs characterization

MabDesign and The Medicine Maker hosted a webinar dedicated to the challenges and solutions of the last development of Capillary electrophoresis (CE) based methods for the characterization of mAbs and related products given by Dr Yannis-Nicolas François from the Strasbourg University.
You can still view the Webinar on demande

Double lauréate, Acticor lève des fonds

Acticor Biotech

Acticor Biotech, qui développe le premier anti-thrombotique sans risque hémorragique pour l’AVC ischémique, cherche à lever 10 à 15 M€ pour poursuivre son développement jusqu’en fin de phase II.

Synthelis célèbre son 5e anniversaire

Synthelis, société française de biotechnologie spécialisée dans la production acellulaire, la purification et la caractérisation de protéines membranaires et autres protéines difficiles à exprimer, a annoncé aujourd’hui sa date anniversaire.

MI-mAbs signe un contrat de recherche portant sur l’évaluation d’anticorps bispécifiques inédits co-développés par Innate Pharma et Sanofi

MI-mAbs, démonstrateur pré-industriel destiné à accélérer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd’hui la signature d’un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera chargé de réaliser les études permettant de d’évaluer l’efficacité et la sécurité des anticorps bispécifiques de nouvelle génération issus de la collaboration entre les deux industriels.

IDD

IDD, société de conseil en Affaires Règlementaires et Stratégie de Développement est organisée autour de 2 grands pôles de compétences complémentaires : – Le Développement et la Gestion de projets; – L’ Exploitation et la stratégie règlementaires tout au long du cycle de vie du médicament. Nous vous accompagnons et conseillons dans le développement de […]

Biomunex Pharmaceuticals

Biomunex Pharmaceuticals est une société biopharmaceutique dédiée à la découverte et au développement de médicaments anticancéreux, sur la base d’anticorps bispécifiques innovants.
Biomunex développe une immunothérapie de pointe contre plusieurs types de cancers en s’appuyant sur une plate-forme unique et propriétaire.

Acticor Biotech

Acticor Biotech

Acticor Biotech is a biopharmaceutical company, spin-off of Inserm (U1148 – Bichat Hospital, Paris, France) founded late 2013, dedicated to developing an innovative treatment in the therapy of acute ischemic stroke, a Fab directed against platelet glycoprotein GPVI. Acticor Biotech’s CEO, Dr Gilles Avenard, is founder and former COO of Onxeo, a Euronext® company. Phase […]

genOway

genOway

genOway designs and develops accurate in vivo and in vitro preclinical models for target validation, compound efficacy assessment and safety studies. The company holds exclusive intellectual property on key technologies for model creation and provides access to more than 10,000 knockout and reporter mouse models of target validation. 14 of the Top 20 Pharmas use […]

Bioproduction des Anticorps thérapeutiques en France

Organisé par MabDesign et Medicen Paris Region en partenariat avec Polepharma et Biocitech. Cet évènement a été destiné aux sociétés (grands groupes et PME) et laboratoires ayant des candidats anticorps thérapeutiques ou développant des outils et services pour leur Bioproduction.

SANOFI investit 300 millions d’euros pour agrandir son site de biologiques en Belgique

SANOFI

Sanofi annonce un investissement de 300 millions d’euros pour l’extension de son site de Geel, en Belgique. Cet investissement témoigne de l’engagement de Sanofi dans le développement des produits biologiques, via l’extension des capacités de fabrication et commerciales afin de garantir la qualité et le volume des activités de production.

IDD Biotech en accord avec Genmab

IDD Biotech annonce la validation d’une étape dans le cadre de l’accord avec Genmab sur l’anticorps DR5. Genmab a sélectionné l’anticorps d’IDD Biotech comme candidat clinique pour poursuivre ses développements.

Ingénierie de l’Anticorps thérapeutique

MabDesign et Lyonbiopôle ont organisé un atelier sur l’ingénierie de l’anticorps thérapeutique. Cet événement satellite de BIOVISION a fait le point sur les différentes approches pour les études structurales et biophysiques de l’anticorps thérapeutique, ainsi que les technologies de leur optimisation et les perspectives associées. Cette journée a rassemblé la communauté travaillant sur l’Anticorps Thérapeutique au niveau national. Elle a permis des échanges sur les axes d’innovation et favorisé les collaborations dans ce domaine.

MabDesign is a partner of the 11th Edition BIOVISION

BIOVISION – The World Life Sciences Forum is an annual meeting, which brings together international decision makers and innovation holders from the academic, private, policy-making and civil society sectors to debate, find partnerships and invest.

Développer des anticorps thérapeutiques : partage d’expériences

MabDesign a organisé, en partenariat avec Lyonbiopôle, une session de partage d’expériences sur la thématique « Développement des anticorps thérapeutiques ». Les sociétés impliquées dans le développement d’anticorps ont partagé leur expérience et leurs besoins technologiques associés. Plus de 40 entreprises ont participé à cet évènement.

SUBSCRIBE TO OUR NEWSLETTER

Become a member
Contact

Follow us

© MabDesign – Legal Notice – Cookies – Design by IGTech